Test the Waters
Macromoltek (yc W18)

Macromoltek (yc W18)

Raised seed funding from Y Combinator, Data Collective VC, Neotribe Ventures, etc. 300+ antibodies engineered & tested. $350k in revenue to date; $450M in the pipeline. Success story includes novel cancer therapeutic designed in <2 weeks, now in pre-clinical trials. Our software-enabled platform reduces traditional process by up to 6x.

Min investment
$100
Goal
-$2M
Days Left
79
Location
Austin, TX

CrowdLustro Research Report

Security Type
Equity
Equity is a stock or any other security representing a direct ownership interest.
Industry
Medical
Filed
April 06, 2021
Expires
July 05, 2021
Valuation Cap
$30M
Deal Structure

Future Equity

Management

Monica Berrondo
Cofounder & CEO
PhD in Chemical Engineering from Johns Hopkins University. Over 15 years Computational Biology leadership. Lead developer of Rosetta Modeling. Austin Founder of the Year. Reviewer for NSF Small Business grants.

Susana Kaufman
Co-founder & CTO
M.SC. Chemical Engineering. Over 20 years in systems development. Developed PageRank for Fintech industry.

Raminderpal Singh
Head of Business Development
Seasoned business development executive, with 20+ years of extensive experience in both the UK and the US. He is passionate about data and computational technologies.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments